Kimberly-Clark Corporation (KMB) Fair Value & Analysis
Consumer Defensive · US · Market cap $36.2B · ISIN US4943681035
What is Kimberly-Clark Corporation really worth?
A solid business, but trading 35% above our fair value of $79.71.
Strengths
Risks
For context
Fair value as of: Aug 30, 2026
From 24 valuation models · updated 6 days ago
Share price −3.2% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- Solid but not exceptional quality (56/100) and above fair value, neither a clear bargain nor a standout compounder.
- A fairly wide model range ($50.13 to $117.98) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 30, 2026.
How to read this chart
60‑month range $91.79 – $139.21 · fair‑value band $50.13 – $117.98 · the $107.95 price screens above the $79.71 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 30, 2026.
Analysis
Kimberly-Clark Corporation (KMB) currently trades at $107.95, while our model-based Fair Value estimate is $79.71, implying the stock looks roughly 35.4% overvalued today. The Quality Score stands at 56/100 (solid quality), in the Consumer Defensive sector. Bull case: the Growth Earnings group reads highest at a median of $96.73 per share, and 3 of the 24 models we run sit above the $107.95 price. Bear case: the Economic Profit group reads lowest at $19.17, and 21 of the 24 models stay below the price. Evidence for this calculation is high.
Over the trailing twelve months, Kimberly-Clark Corporation generated revenue of $16.6B at a net margin of 12.8%. Revenue grew 2.7% year over year. It earns a return on equity of 111.7%. Net debt stands at $6.5B. Fundamentals as of Aug 30, 2026
Our scenario range runs from $50.13 (bear case) to $117.98 (bull case); at $107.95, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 18% below its 52-week high and 18% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at −36% fair-value upside, at −26%, KMB screens cheaper than that median.
Fair Value models
This estimate rests on fiscal year 2025 figures, and about 8 months have passed since. In that time the company retained roughly $0.0744 per share, which is 0.1 % of the fair value. The fair value deliberately does not add this in: the models value reported figures, not a projection.
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 24 models by family
Widest divergence: Growth Earnings ($96.73) versus Asset-Based ($3.03). Highest evidence: FCF DCF (78).
Notify me when KMB reaches fair value
Put KMB on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 30, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 54 · Market factors (momentum, volatility) 54
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care products in the United States. It operates in two segments, North America and International Personal Care.
Full company description
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care products in the United States. It operates in two segments, North America and International Personal Care. The North America segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, facial and bathroom tissue, paper towels, napkins, wipers, tissue, towels, soaps and sanitizers, and other related products under the Huggies, Pull-Ups, Goodnites, Kotex, Poise, Depend, Kleenex, Scott, Cottonelle, Viva, Wypall , and other brand names. Its International Personal Care segment provides baby and child care, adult care and feminine care, including disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Kotex, Goodfeel, Intimus, Depend, and other brand names. The company sells its household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce. It also sells its professional use products through distributors, directly to manufacturing, lodging, office building, food service, and high-volume public facilities, and through e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Kimberly-Clark Corporation reported revenue of $17.2B in FY2025 versus $19.4B in FY2021, a compound −3.0%/yr. Reported net income was $2.0B in FY2025, compounding +2.7%/yr from FY2021.
of which total revenue +0.2 % · buybacks/dilution +1.0 %
Annual growth per factor. These are factors, not summands: multiplied they give the EPS growth rate, added they do not quite. Start and end points are 3-year averages (details on hover).
KMB screens 35% overvalued. Compare with L'Oréal S.A →
Recent news
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.
- Kimberly-Clark to Webcast its Presentation at Barclays 19th Annual Global Consumer Staples Conference
- Can Kimberly-Clark's Innovation Pipeline Power Its Next Growth Phase?
Peer Group
Household & Personal Products · 244 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Household & Personal Products median · lower = cheaper
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Insider activity: 35/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Aug 30, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| L'Oréal S.A LORL | C$24.76 | C$22.64 | −9% |
| Unilever PLC UNA | €55.92 | €40.47 | −28% |
| Colgate-Palmolive Company CL | $90.75 | $55.28 | −39% |
| 500696 500696 | ₹2,093 | ₹641.55 | −69% |
| Hindustan Unilever Limited HINDUNILVR | ₹2,015 | ₹789.46 | −61% |
| Kenvue Inc KVUE | $18.95 | $10.97 | −42% |
| Henkel AG HEN3 | €75.82 | €85.95 | +13% |
| The Estée Lauder Companies Inc ESLA | €86.54 | €18.84 | −78% |
| Church & Dwight Co CHD | $101.26 | $65.12 | −36% |
| Beiersdorf Aktiengesellschaft, BEI | €80.42 | €68.36 | −15% |
Compare Kimberly-Clark Corporation with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Kimberly-Clark Corporation (KMB) overvalued or undervalued?
What is the fair value of KMB?
What is the quality score of KMB?
What is the revenue of Kimberly-Clark Corporation (KMB)?
What is the net profit margin of KMB?
Does Kimberly-Clark Corporation pay a dividend?
Watch Kimberly-Clark Corporation in the live analysis
One click puts Kimberly-Clark Corporation on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.